Pharma Meeting Brazil ’s Post

💊 Is the pharmaceutical industry passing up chances to expand in developing nations and emerging markets? 💊How can pharmaceutical companies improve their efforts to promote health equity on a global scale? 💊How are the strategies implemented by top players in the industry? 💊 While still being true to your word on health equity, how can your company take advantage of opportunities in low- and middle-income countries? Join me and my colleague Joshua Siow as we explore the untapped opportunities these markets offer and discuss promoting global healthcare equity while meeting ESG targets in the pharma industry.   Register here: https://lnkd.in/ecCcPqjm #HealthcareEquity #PharmaGrowth #SimonKucher #BetterMarketAccess

🌍🎧 Dive into the "Global vs Local" dynamics within pharmaceutical companies on today's episode! Uncover the challenges and opportunities in bridging the gap between global strategies and local operations. Perfect for anyone in the pharma industry looking to enhance collaboration and impact. 💊🔬 👉 Listen, learn, and let's drive change together! Share with your network and spark a conversation on the crucial balance between global reach and local effectiveness. 🎙️ Tune in now! https://lnkd.in/eAjmcSGN #TheEffectiveStatistician #PharmaIndustry #GlobalVsLocal

Our piece in the Autumn issue of International Clinical Trials outlines key strategies for pharmaceutical service providers to establish successful partnerships. The roadmap emphasises the importance of market intelligence, identifying potential partners, and meticulous planning. 📖Read the full article on page 78 of the latest ICT/EPC issue: https://lnkd.in/epRncQU7 International #ClinicalTrials, November 2023, pages 78-80. © Samedan Ltd. Since 2013, we have helped our clients connect with the right decision-makers in the #pharma, #biotech, and #medtech industries. We look forward to continuing our mission of connecting people intelligently in the pharma and biotech service providers. 👉 𝗜𝗳 𝘆𝗼𝘂'𝗱 𝗹𝗶𝗸𝗲 𝘁𝗼 𝗸𝗻𝗼𝘄 𝗺𝗼𝗿𝗲, 𝗽𝗹𝗲𝗮𝘀𝗲 𝗳𝗲𝗲𝗹 𝗳𝗿𝗲𝗲 𝘁𝗼 𝘀𝗲𝗻𝗱 𝘂𝘀 𝗮 𝗺𝗲𝘀𝘀𝗮𝗴𝗲 𝗼𝗻 𝗟𝗶𝗻𝗸𝗲𝗱𝗜𝗻. #PharmaTargeting - The home of Pharma Service Providers. #marketintelligence #pharmaceuticalservices

Pharma's reputation is on the mend post-COVID, but regional nuances demand attention. 💊 RepTrak’s 2024 Pharma Report reveals a global Reputation Score of 70.2 points for the industry — but that Score isn't consistent across markets. The Pharmaceutical sector is seeing positive momentum in the pandemic's wake, but continued public pressures aren't letting up. Read the latest report on our new Reputation Intelligence for Pharma page, and see how Pharma companies can meet the evolving needs of stakeholders. ⬇ https://lnkd.in/g_4ZEHHP

Pharma Sector Prospects Under BJP vs Congress... Let’s explore the possible potential growth of the pharmaceutical sector under Congress vs. BJP. Though political landscape is dynamic, and regional issues and alliances will play critical roles in the final outcome, still both parties have different strengths and challenges for the pharmaceutical sector. The BJP’s approach may lead to higher profitability and faster market expansion, while the Congress’s approach could result in broader access to healthcare and increased demand. For more details -  https://lnkd.in/gTsDKRGF #pharmaceuticalsector #pharma #BJP #Congress #CongressvsBJP #leadership #PotentialGrowthofthePharmaceuticalSector #RegulatoryStreamlining #HealthcareInfrastructure #ExportGrowth #DomesticDemand #InvestmentClimate #TaxPolicies #PublicPrivatePartnerships #InnovationandRandD #HistoricalContextandPolicies #HealthcareAccess #PriceControls #foreigndirectinvestment  #PublicHealthPrograms

Discover Key Industry Trends at Pharma Europe 2024! Pharma Europe 2024 is your ultimate gateway to the most significant trends shaping the #pharmaceutical_industry. Join us in Frankfurt, Germany, on July 25-26, 2024, for an event that will offer you exceptional insights and a glimpse into the future of #pharma. Here’s why this is an unmissable opportunity. Importance: •            Expand Your Network •            Drive Strategic Decisions •            Enhance Your Expertise •            Stay Ahead of the Curve #PharmaEurope2024 #CareerAdvancement #IndustryExperts #ProfessionalDevelopment #NetworkingOpportunities #IndustryInsights #SuccessStories

📊 Key Highlights from the RepTrak Pharma Report 2024: - Global reputation score hits 70.2 📈 - U.S. trust remains low despite global recovery 🤔 - Gains in Leadership (75.1) 💼 and Products (73.9) 💊 - Innovation shows minimal growth (+0.5) ⚡️ Are you keeping pace with rising expectations? #Pharma #Reputation #Innovation #Leadership #Healthcare

🔎Let's take a step back to the origins of the pharmaceutical industry. In Switzerland, F. Hoffmann-La Roche AG (commonly known as Roche) is considered the first pharmaceutical company, founded in 1896. At that time, the entire process from the initial sketch to physical models, on to calculations/checks, was done manually by hand. This was accompanied by time-consuming protocols, such as communicating between different departments and manual, handwritten documentation.   ❓This procedure is hardly imaginable today. Now, how do we make our contribution in an increasingly modern society?   ⌛To be continued on Thursday! Aseptsoft® powered by Aseptconn AG #PharmaceuticalHistory #SwissInnovation #Evolution #ProcessDesign

Vantage BioTrials continues to expand our strategic reach into Europe through a new partnership with Pharmaxi LLC, broadening our capabilities further to offer our Sponsors more options for faster patient recruitment while maintaining high-quality standards. Contact us today to find out more about how we can help you with your clinical development goals [email protected]. #clinicaltrials #clinicaltrial #clinicaldevelopment #clinicalresearch #drugdevelopment #clinicaloperations #pharmaceutical #pharmaceuticalresearch

Want to understand what’s driving reputation in pharma?? RepTrak’s latest insights reveal how pharma companies can build trust and accountability in a sector under constant scrutiny. In a world where transparency is key, knowing the key drivers of reputation makes all the difference.